XML 23 R8.htm IDEA: XBRL DOCUMENT v2.3.0.15
Business Segment Information
9 Months Ended
Sep. 30, 2011
Business Segment Information 
Business Segment Information

NOTE C—Business Segment Information

        The accounting policies of the Company's segments are the same as those described in Note A—"General." The Company evaluates performance of its segments based on profit or loss from operations before stock compensation expense, depreciation and amortization, interest expense, interest income, gain on sale of assets, special charges or benefits, and income taxes ("Segment Profit"). Management uses Segment Profit information for internal reporting and control purposes and considers it important in making decisions regarding the allocation of capital and other resources, risk assessment and employee compensation, among other matters. Effective September 1, 2010, Public Sector has subcontracted with Medicaid Administration to provide pharmacy benefits management services on a limited risk basis for one of Public Sector's customers. As such, revenue and cost of care related to this intersegment arrangement are eliminated. The Company's segments are defined above.

        The following tables summarize, for the periods indicated, operating results by business segment (in thousands):

Three Months Ended
September 30, 2010
  Commercial   Public
Sector
  Radiology
Benefits
Management
  Specialty
Pharmaceutical
Management
  Medicaid
Administration
  Corporate
and
Elimination
  Consolidated  

Net revenue

  $ 165,270   $ 364,102   $ 116,379   $ 68,609   $ 42,606   $ (6,647 ) $ 750,319  

Cost of care

    (84,485 )   (310,261 )   (72,980 )       (6,081 )   6,647     (467,160 )

Cost of goods sold

                (55,071 )           (55,071 )

Direct service costs

    (40,156 )   (17,554 )   (17,366 )   (8,064 )   (27,928 )       (111,068 )

Other operating expenses

                        (30,513 )   (30,513 )

Stock compensation expense(1)

    124     181     362     108     36     2,785     3,596  
                               

Segment profit (loss)

  $ 40,753   $ 36,468   $ 26,395   $ 5,582   $ 8,633   $ (27,728 ) $ 90,103  
                               

 

Three Months Ended
September 30, 2011
  Commercial   Public
Sector
  Radiology
Benefits
Management
  Specialty
Pharmaceutical
Management
  Medicaid
Administration
  Corporate
and
Elimination
  Consolidated  

Net revenue

  $ 135,365   $ 362,104   $ 78,659   $ 73,792   $ 57,692   $ (20,769 ) $ 686,843  

Cost of care

    (81,503 )   (318,807 )   (49,186 )       (19,324 )   20,769     (448,051 )

Cost of goods sold

                (57,636 )           (57,636 )

Direct service costs

    (36,582 )   (16,741 )   (14,717 )   (6,563 )   (26,221 )       (100,824 )

Other operating expenses

                        (29,214 )   (29,214 )

Stock compensation expense(1)

    208     218     355     380     36     3,228     4,425  
                               

Segment profit (loss)

  $ 17,488   $ 26,774   $ 15,111   $ 9,973   $ 12,183   $ (25,986 ) $ 55,543  
                               

 

Nine Months Ended
September 30, 2010
  Commercial   Public
Sector
  Radiology
Benefits
Management
  Specialty
Pharmaceutical
Management
  Medicaid
Administration
  Corporate
and
Elimination
  Consolidated  

Net revenue

  $ 487,954   $ 1,081,581   $ 331,099   $ 204,740   $ 121,303   $ (6,647 ) $ 2,220,030  

Cost of care

    (265,740 )   (930,932 )   (220,211 )       (6,081 )   6,647     (1,416,317 )

Cost of goods sold

                (166,138 )           (166,138 )

Direct service costs

    (115,340 )   (50,559 )   (47,605 )   (19,537 )   (94,555 )       (327,596 )

Other operating expenses

                        (91,856 )   (91,856 )

Stock compensation expense(1)

    556     554     1,123     365     76     9,156     11,830  
                               

Segment profit (loss)

  $ 107,430   $ 100,644   $ 64,406   $ 19,430   $ 20,743   $ (82,700 ) $ 229,953  
                               

 

Nine Months Ended
September 30, 2011
  Commercial   Public
Sector
  Radiology
Benefits
Management
  Specialty
Pharmaceutical
Management
  Medicaid
Administration
  Corporate
and
Elimination
  Consolidated  

Net revenue

  $ 425,086   $ 1,074,904   $ 258,479   $ 213,388   $ 167,622   $ (61,543 ) $ 2,077,936  

Cost of care

    (235,938 )   (933,662 )   (157,731 )       (57,409 )   61,543     (1,323,197 )

Cost of goods sold

                (167,559 )           (167,559 )

Direct service costs

    (113,502 )   (50,203 )   (47,280 )   (18,658 )   (78,056 )       (307,699 )

Other operating expenses

                        (85,685 )   (85,685 )

Stock compensation expense(1)

    677     654     1,238     639     100     10,100     13,408  
                               

Segment profit (loss)

  $ 76,323   $ 91,693   $ 54,706   $ 27,810   $ 32,257   $ (75,585 ) $ 207,204  
                               

(1)
Stock compensation expense is included in direct service costs and other operating expenses, however this amount is excluded from the computation of Segment Profit since it is managed on a consolidated basis.

        The following table reconciles Segment Profit to income before income taxes (in thousands):

 
  Three Months Ended
September 30,
  Nine Months Ended
September 30,
 
 
  2010   2011   2010   2011  

Segment profit

  $ 90,103   $ 55,543   $ 229,953   $ 207,204  

Stock compensation expense

    (3,596 )   (4,425 )   (11,830 )   (13,408 )

Depreciation and amortization

    (13,950 )   (15,069 )   (41,607 )   (43,288 )

Interest expense

    (482 )   (457 )   (1,751 )   (1,422 )

Interest income

    846     592     2,466     2,265  
                   
 

Income before income taxes

  $ 72,921   $ 36,184   $ 177,231   $ 151,351